首页> 外文期刊>Bulletin of the Korean Chemical Society >Synthesis and Bioactivity of Novel Adamantyl Derivatives as Potent MDR Reversal Agents
【24h】

Synthesis and Bioactivity of Novel Adamantyl Derivatives as Potent MDR Reversal Agents

机译:新型金刚烷基衍生物作为强效MDR逆转剂的合成及生物活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Multidrug Resistance (MDR) is a type of resistance of tumor cells to various kinds of chemotherapeutic drugs which are structurally unrelated and also one of the major impediments to chemotherapeutic treatment of cancer. It has been reported that 49 ATP-binding cassette (ABC) transporter genes are present in the human genome. Among them, over-expression of P-glycoprotein (P-gp), encoded by MDR1 gene is one of the major factors contributing to multidrug resistance which leads to barrier to successful chemotherapy.
机译:多药抗性(MDR)是肿瘤细胞对各种化学疗法药物的抗性类型,这些化学疗法药物在结构上不相关,并且也是癌症化学疗法治疗的主要障碍之一。据报道,人类基因组中存在49个ATP结合盒(ABC)转运蛋白基因。其中,由MDR1基因编码的P-糖蛋白(P-gp)的过表达是导致多药耐药性的主要因素之一,导致成功化疗的障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号